Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > Hard to compalin about this stock.
View:
Post by fairchij on Sep 23, 2011 11:45pm

Hard to compalin about this stock.

The TSX is down about 18% in the last 6 months, MDG up about 35%. I was very relieved to see that they were able to secure financing under the current market conditions at above the prevailing market price. It also appears like the major pharma they are currently collaborating with for non-influenza vaccines are taking down part (probably a large part of this financing). I seriously think you should be happy with growth potential. The interest by major pharma sure provides a level of confidence in the technology.By the way good news is good news when ever it is issued. Bad news is best issued on a Friday. I see this as a good news release.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities